Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyMon, 22 Jul 2024 14:24:52 +0200Mon, 22 Jul 2024 11:16:00 +0200Lopinavir/Ritonavir Viatris : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4025-en.pdfLopinavir/Ritonavir Viatris : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4025-en.pdfMon, 22 Jul 2024 11:16:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 18, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/lopinavir-ritonavir-viatrisHuman medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 18, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/lopinavir-ritonavir-viatrisMon, 22 Jul 2024 10:54:00 +0200Human medicine